AstraZeneca PLC Files Form 6-K
Ticker: AZN · Form: 6-K · Filed: Aug 15, 2025 · CIK: 901832
| Field | Detail |
|---|---|
| Company | Astrazeneca PLC (AZN) |
| Form Type | 6-K |
| Filed Date | Aug 15, 2025 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 4 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-issuer, routine-disclosure
Related Tickers: AZN
TL;DR
AZN filed a 6-K, confirming 20-F reporting. Standard stuff.
AI Summary
AstraZeneca PLC filed a Form 6-K on August 15, 2025, reporting its status as a foreign issuer. The filing confirms that AstraZeneca is submitting its annual reports under Form 20-F. The company is incorporated in the UK with its principal executive offices located in Cambridge.
Why It Matters
This filing is a routine disclosure for foreign issuers, confirming their reporting obligations and providing basic company information to the SEC and investors.
Risk Assessment
Risk Level: low — This is a routine administrative filing for a foreign issuer and does not contain new material financial or operational information.
Key Players & Entities
- AstraZeneca PLC (company) — Filer of the Form 6-K
- 0001654954-25-009692 (filing_id) — Accession Number for the filing
- 20250815 (date) — Filing date and period of report
- 001-11960 (commission_file_number) — SEC file number for AstraZeneca PLC
- Form 20-F (document_type) — Annual report form filed by the registrant
- Form 6-K (document_type) — Type of report being filed
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign issuer submitted pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, used to provide information that the company makes or is required to make public in its home country or to shareholders.
Which annual report form does AstraZeneca PLC file?
AstraZeneca PLC files its annual reports under cover of Form 20-F.
What is AstraZeneca PLC's Central Index Key (CIK)?
AstraZeneca PLC's Central Index Key is 0000901832.
Where are AstraZeneca PLC's principal executive offices located?
AstraZeneca PLC's principal executive offices are located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.
What is the filing date of this Form 6-K?
This Form 6-K was filed on August 15, 2025.
Filing Stats: 1,104 words · 4 min read · ~4 pages · Grade level 9.8 · Accepted 2025-08-15 10:40:25
Filing Documents
- a5241v.htm (6-K) — 66KB
- 0001654954-25-009692.txt ( ) — 68KB
SIGNATURES
SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     AstraZeneca PLC     Date: 15 August 2025     By: /s/ Matthew Bowden   Name: Matthew Bowden   Title: Company Secretary